John­son & John­son do­nates Ebo­la vac­cine amid new out­break; Ji Xing promis­es more than $127M for Mile­stone's nasal spray for rapid heart rate

As John­son & John­son con­tin­ues to roll out its Covid-19 shot, the com­pa­ny is al­so fo­cused on an­oth­er vac­cine.

J&J is do­nat­ing up to 200,000 dos­es of its Ebo­la vac­cine reg­i­men de­vel­oped with Bavar­i­an Nordic to help health au­thor­i­ties deal with a new out­break in Sier­ra Leone. The reg­i­men, Zab­de­no and Mv­abea, was grant­ed pre­qual­i­fi­ca­tion by the WHO in April, which will help ac­cel­er­ate its reg­is­tra­tion in coun­tries where Ebo­la is a threat.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER